State of Wyoming Raises Position in Amrize Ltd $AMRZ

State of Wyoming increased its stake in shares of Amrize Ltd (NYSE:AMRZFree Report) by 115.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 25,898 shares of the company’s stock after purchasing an additional 13,852 shares during the quarter. State of Wyoming’s holdings in Amrize were worth $1,451,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. MCF Advisors LLC bought a new position in Amrize during the 4th quarter valued at about $27,000. Basepoint Wealth LLC bought a new position in shares of Amrize during the fourth quarter valued at approximately $33,000. Laurel Wealth Advisors LLC purchased a new stake in shares of Amrize in the fourth quarter worth approximately $34,000. US Bancorp DE purchased a new stake in shares of Amrize in the third quarter worth approximately $38,000. Finally, Itau Unibanco Holding S.A. lifted its stake in shares of Amrize by 150.0% during the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock worth $41,000 after acquiring an additional 450 shares during the last quarter.

Analysts Set New Price Targets

AMRZ has been the subject of a number of research reports. Wells Fargo & Company lowered their price target on Amrize from $65.00 to $58.00 and set an “overweight” rating for the company in a report on Wednesday, July 8th. Sanford C. Bernstein reiterated an “outperform” rating on shares of Amrize in a report on Monday, June 22nd. Stephens reissued an “overweight” rating and set a $65.00 target price on shares of Amrize in a research report on Monday, May 18th. Weiss Ratings cut shares of Amrize from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, July 13th. Finally, Vertical Research raised shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective on the stock in a report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, Amrize has a consensus rating of “Moderate Buy” and an average target price of $62.79.

View Our Latest Research Report on Amrize

Insider Activity at Amrize

In other news, CTO Roald Brouwer bought 1,500 shares of the business’s stock in a transaction that occurred on Thursday, May 21st. The shares were purchased at an average cost of $49.84 per share, with a total value of $74,760.00. Following the transaction, the chief technology officer directly owned 19,757 shares in the company, valued at approximately $984,688.88. The trade was a 8.22% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Nollaig Forrest purchased 2,000 shares of the stock in a transaction on Friday, May 22nd. The shares were purchased at an average cost of $50.25 per share, with a total value of $100,500.00. Following the transaction, the insider owned 20,139 shares in the company, valued at $1,011,984.75. This trade represents a 11.03% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought 54,920 shares of company stock valued at $2,717,429 over the last three months. 0.54% of the stock is owned by corporate insiders.

Amrize Trading Up 2.0%

NYSE:AMRZ opened at $49.66 on Thursday. The firm has a 50 day moving average of $52.14 and a 200 day moving average of $55.20. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $65.94. The stock has a market capitalization of $27.46 billion and a price-to-earnings ratio of 23.76.

Amrize (NYSE:AMRZGet Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). Amrize had a return on equity of 9.84% and a net margin of 9.70%.The business had revenue of $2.18 billion during the quarter. The firm’s revenue was up 4.7% on a year-over-year basis. As a group, sell-side analysts anticipate that Amrize Ltd will post 2.74 earnings per share for the current fiscal year.

Amrize Cuts Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were paid a dividend of $0.11 per share. The ex-dividend date was Tuesday, May 12th. Amrize’s payout ratio is presently 21.05%.

About Amrize

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Read More

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.